We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

1 hedge funds and large institutions have $159K invested in Array Biopharma Inc in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 316 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 318 → 1 (-317)

100% less funds holding in top 10

Funds holding in top 10: 28 → 0 (-28)

100% less capital invested

Capital invested by funds: $10.5B → $159K (-$10.5B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 316

Holders
1
Holders Change
-317
Holders Change %
-99.69%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-28
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
316
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$943M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$890M
3
BlackRock
BlackRock
New York
-$824M
4
RG
Redmile Group
California
-$405M
5
FCM
Farallon Capital Management
California
-$394M
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
301
US Bancorp
Minnesota
– -$20K -428 Closed
PGAM
302
Princeton Global Asset Management
New Jersey
– -$15K -330 Closed
LJHT
303
Laurie J. Hall Trustee
– -$13K -285 Closed
NCM
304
Next Capital Management
New York
– -$11K -229 Closed
TC
305
Truvestments Capital
Florida
– -$10K -214 Closed
FHA
306
Flagship Harbor Advisors
Massachusetts
– -$9K -213 Closed
BCA
307
Berman Capital Advisors
Georgia
– -$8K -194 Closed
PCP
308
Proficio Capital Partners
Massachusetts
– -$9K -184 Closed
FPFS
309
First Personal Financial Services
North Carolina
– -$8K -162 Closed
BWA
310
BDO Wealth Advisors
Florida
– -$7K -160 Closed
SPIA
311
Steward Partners Investment Advisory
New York
– -$6K -150 Closed
BBHC
312
Brown Brothers Harriman & Co
New York
– -$6K -134 Closed
ARMC
313
American Research & Management Company
Massachusetts
– -$5K -100 Closed
Northwestern Mutual Wealth Management
314
Northwestern Mutual Wealth Management
Wisconsin
– -$2K -50 Closed
TCOV
315
Trust Company of Vermont
Vermont
– -$2K -43 Closed
Parallax Volatility Advisers
316
Parallax Volatility Advisers
California
– -$2K -42 Closed
9 10 11 12
13

ARRY Hedge Fund Activity: Q3 2019 in Review

1 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q3 2019, worth a combined $159K — down 100% from $10.5B a quarter earlier.

Sellers outnumbered buyers: 316 funds closed out of ARRY and 0 opened new positions — a net loss of 316 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $943M sold.

  • 1 institutional investor held Array Biopharma Inc (ARRY) as of Q3 2019, down from 318 in Q2 2019.
  • Funds reported $159K of Array Biopharma Inc stock for Q3 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Array Biopharma Inc positions in Q3 2019 and 316 closed out, a net change of -316 holders.
  • The largest Array Biopharma Inc seller in Q3 2019 was Vanguard Group, an estimated $943M sold.

Based on aggregated 13F filings for Q3 2019.